Information Journal Paper
APA:
Copy. (2019). Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY, 47(1), 0-0. SID. https://sid.ir/paper/976328/en
Vancouver:
Copy. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY[Internet]. 2019;47(1):0-0. Available from: https://sid.ir/paper/976328/en
IEEE:
Copy, “Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy,” ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY, vol. 47, no. 1, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/976328/en